Dr Rebecca Johnson
Research Officer
Department of Microbiology and Immunology
19 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
GS-1 blocks entry of herpes viruses and more broadly inhibits enveloped viruses
DOI: 10.1016/j.antiviral.2025.1061362023
Journal article
The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility
DOI: 10.1093/protein/gzad0082022
Journal article
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
DOI: 10.1038/s41467-022-33030-42022
Journal article
IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2
DOI: 10.1126/sciimmunol.abl99432021
Journal article
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens
DOI: 10.1002/adhm.2021013702021
Journal article
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
DOI: 10.1016/j.chom.2021.08.0022021
Journal article
Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID‐19 Vaccines (Adv. Sci. 18/2021)
DOI: 10.1002/advs.202170111
RECENT SCHOLARLY WORKS
2021
Journal article
Identification and characterization of defective viral genomes in ebola virus-infected rhesus macaques
DOI: 10.1128/JVI.00714-212021
Journal article
Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines
DOI: 10.1002/advs.2021003162021
Journal article
Correction: Johnson et al. Alston virus, a novel paramyxovirus isolated from bats causes upper respiratory tract infection in experimentally challenged ferrets. Viruses 2018, 10, 675
DOI: 10.3390/v13071204